Literature DB >> 10931164

An audit of delays in diagnosis and treatment of lymphoma in district hospitals in the northern region of the United Kingdom.

G P Summerfield1, P J Carey, M J Galloway, H N Tinegate.   

Abstract

Prompt diagnosis and treatment of malignant disorders is generally regarded as improving outcomes. There is good evidence for this in the most common solid tumours, bronchus, breast and large bowel. It might be expected that delays in diagnosis of lymphoma could affect the outcome of treatment, as well as causing dissatisfaction among patients and relatives. However it would be difficult to obtain definite evidence for this as a randomised trial of delay is an unethical proposition. The recently introduced National Priorities Guidance (NPG) Cancer Targets require that all new patients with suspected cancer should see a specialist within two weeks of referral by their General Practitioner (GP). There is no good evidence to support this requirement in lymphoma, but we decided to audit delays at different stages of the process of diagnosis and initial treatment of lymphoma as a base line to assess current performance, identify possible shortcomings and set achievable standards amenable to further audit.

Entities:  

Mesh:

Year:  2000        PMID: 10931164     DOI: 10.1046/j.1365-2257.2000.00303.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  8 in total

1.  Waiting time to lymph node biopsy is dependent on referral method: don't write, phone!

Authors:  S A J Pannick; C L Ingham Clark
Journal:  Ann R Coll Surg Engl       Date:  2009-09-25       Impact factor: 1.891

2.  Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients.

Authors:  Andrea Kühnl; David Cunningham; Margaret Hutka; Clare Peckitt; Hamoun Rozati; Federica Morano; Irene Chong; Angela Gillbanks; Andrew Wotherspoon; Michelle Harris; Tracey Murray; Ian Chau
Journal:  BMC Hematol       Date:  2018-08-14

3.  The determinants and impact of diagnostic delay in lymphoma in a TB and HIV endemic setting.

Authors:  Katherine Antel; Carly Levetan; Zainab Mohamed; Vernon J Louw; Jenna Oosthuizen; Gary Maartens; Estelle Verburgh
Journal:  BMC Cancer       Date:  2019-04-25       Impact factor: 4.430

4.  The impact of structural factors on diagnostic delay in diffuse large B-cell lymphoma.

Authors:  Joanna C Zurko; Raymond C Wade; Amitkumar Mehta
Journal:  Cancer Med       Date:  2019-03-18       Impact factor: 4.452

5.  Diagnostic Interval in Extranodal Non-Hodgkin Head and Neck Lymphomas.

Authors:  Alba Bello Castro; Juan Seoane; Máximo Francisco Fraga Rodríguez; Francisco Gude Sampedro; Javier Seoane Romero; Benjamín Martin-Biedma; Pablo Castelo-Baz
Journal:  J Clin Med       Date:  2022-02-06       Impact factor: 4.241

6.  Rapid access multidisciplinary lymph node diagnostic clinic: analysis of 550 patients.

Authors:  I Chau; M T Kelleher; D Cunningham; A R Norman; A Wotherspoon; P Trott; P Rhys-Evans; G Querci Della Rovere; G Brown; M Allen; J S Waters; S Haque; T Murray; L Bishop
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

7.  Time-to-diagnosis and symptoms of myeloma, lymphomas and leukaemias: a report from the Haematological Malignancy Research Network.

Authors:  Debra A Howell; Alexandra G Smith; Andrew Jack; Russell Patmore; Una Macleod; Emma Mironska; Eve Roman
Journal:  BMC Hematol       Date:  2013-10-31

8.  Risk factors and time to symptomatic presentation in leukaemia, lymphoma and myeloma.

Authors:  Debra A Howell; Fiona Warburton; Amanda-Jane Ramirez; Eve Roman; Alexandra G Smith; Lindsay J L Forbes
Journal:  Br J Cancer       Date:  2015-09-01       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.